We are a clinical-stage, biotechnology company developing a urine screen for early detection of prostate/bladder cancer as well as novel molecular imaging diagnostics in Cancer and Cardiovascular Disease. Our products address urgent unmet medical needs in the detection and diagnosis of cancer. These products will reduce unnecessary, invasive and expensive medical procedures that will benefit patient quality of care and healthcare payor costs.